Skip to main content

AI

By Jessica Hagen | 01:33 pm | November 30, 2023
The company scored Class III Shonin clearance in Japan for its stroke platform and launched Rapid Edge Cloud, allowing continued AI access despite cloud connectivity.
By Nathan Eddy | 05:35 pm | November 29, 2023
The medtech company announced 40 innovations at RSNA23 aimed at streamlining the provider and patient healthcare experience.
By HIMSS TV | 07:00 am | November 29, 2023
EHR giant Epic’s executive vice president of research and development, Sumit Rana, discusses generative AI use in healthcare, the benefits and pitfalls of the tool, and how providers use the company's technology for clinical workflow.  
By Jessica Hagen | 06:10 pm | November 28, 2023
The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.
By Jessica Hagen | 01:07 pm | November 28, 2023
The company showcased new informatics solutions at RSNA23 in Chicago, including a "helium-free" mobile MRI system and an AI-enabled advanced visualization workshop.
By HIMSS TV | 07:00 am | November 28, 2023
In-Young Choi, director at Catholic Information Convergence Institute at CMC in South Korea, discusses how data from eight hospitals is converged and distributed to meet an individual department's needs, aiding in the creation of AI solutions.  
By Jessica Hagen | 02:21 pm | November 27, 2023
A study published in the New England Journal of Medicine says GPT-4 correctly diagnosed 52.7% of complex cases compared to only 36% of medical journal readers.
By Jessica Hagen | 05:12 pm | November 22, 2023
The company's product, Distill, uses machine learning algorithms and LLMs to perform administrative, clinical and research tasks that require chart review.
By Jessica Hagen | 04:18 pm | November 22, 2023
The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.
By Nathan Eddy | 12:19 pm | November 22, 2023
The pharma giant's new health tech company will operate as a separate business and scale the company's already established digital technologies to enhance clinical trials.